NCT04928014 - Validation of a Tear-based Screening Assay for Breast Cancer | Biotech Hunter

Enrollment

205

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2025

Conditions

HealthyBreast CancerBreast Cancer FemaleHealth Care UtilizationHealth Knowledge, Attitudes, PracticeHealth Personnel AttitudeHealth Care Acceptability

Interventions

OTHER

Schirmer Strip

A tear-based screening assay for breast cancer developed and validated by Namida Lab, Inc., a high complexity CLIA-certified lab. It consists of two parts: tear sample collection using a Schirmer Strip and a clinical lab-developed test that measures protein biomarkers for breast cancer screening.

Trial Locations (1)

72703

Namida Lab, Fayetteville